Uncontrolled blood sugar tends to increase prevalence of dermatomycosis in diabetic type 2 patients
Article Sidebar
Main Article Content
Abstract
The prevalence of type 2 diabetes mellitus (DM) is increasing. Diabetic patients have a higher risk of getting dermatomycosis. Dermatomycoses, although a common health problem amongst DM, is often misdiagnosed and consequently undertreated. Studies on the association between dermatomycosis and type 2 diabetes are lacking, especially in Indonesia. Therefore, the aim of this study was to determine the prevalence, etiology, and association of dermatomycosis with diabetic control of type 2 DM.
Methods
A cross-sectional study was performed involving 87 subjects with type 2 DM. Demographic and clinical data, including age, sex, and blood glucose level, were collected. If a dermatomycosis lesion was found, a specimen would be taken for identification. Determination of serum glucose level was conducted using Roche c111 analyzer®. Statistical analysis was performed with the chi-square test and Kolmogorov-Smirnov two-independent sample test.
Results
Seventeen (19.55%) subjects had dermatomycosis. The predominant age group affected was 51 - 60 years (42.4%). The number of clinically apparent dermatomycosis was greater in the uncontrolled than in the controlled blood sugar group, but the difference was statistically not significant (p > 0.05). The lesions were mostly found on the nails (74%) and the most common etiology was candida (50%) followed by dermatophyte (25%) and non-dermatophyte molds (25%).
Conclusion
Uncontrolled blood sugar tends to increase the risk of dermatomycosis in type 2 DM patients. Fungal skin infections are common in type-2 DM patients, especially in those with poor glycemic control.
Article Details
Issue
Section
The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.
How to Cite
References
Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018;138:271–81. doi: 10.1016/j.diabres.2018.02.023.
Soelistijo SA, Novida H, Rudijanto A, et al. Konsensus: pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia. 1st ed. Jakarta: PB Perkeni; 2015.
Schieke SM, Garg A. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw Hill; 2012.
Havlickova B, Czaika VA, Fredrich M. Epidemiological trends in skin mycosis worldwide. Mycosis 2008;51:2-15. doi: 10.1111/j.1439-0507.2008.01606.
Hayette MP, Sacheli R. Dermatophytosis, trends in epidemiology and diagnostic approach. Curr Fungal Infect Rep 2015;9:164-79. doi: 10.1007/s12281-015-0231-4.
Mehlig L, Garve C, Ritschel A, et al. Clinical evaluation of a novel commercial multiplex-based PCR diagnostic test for differential diagnosis of dermatomycoses. Mycoses 2014;57:27-34. doi: 10.1111/myc.12097.
Nenoff P, Kruger C, Ginter-Hanselmayer G, et al. Mycology - an update. Part 1: dermatomycoses: causative agents, epidemiology and pathogenesis. J Dtsch Dermatol Ges 2014;12:188-212. doi: 10.1111/ddg.12245.
Qadim HH, Golforoushan F, Azimi H, et al. Factors leading to dermatophytosis. Ann Parasitol 2013;59:99-102.
Parada H, Veríssimo C, Brandão J, et al. Dermatomycosis in lower limbs of diabetic patients followed by podiatry consultation. Rev Iberoam Micol 2013;30:103–8. doi: 10.1016/j.riam.2012.09.007.
Powers AC. Diabetes mellitus. In: Jameson JL, editor. Harrison’s endocrinology. 2nd ed. New York: McGraw Hill;2010.p.267-313.
Ngwogu A, Ngwogu K, Mba I, et al. Pattern of presentation of dermatomycosis in diabetic patients in Aba, South-eastern, Nigeria. J Med Investigations Pract 2014;9:10-3. doi: 10.4103/9783-1230.139164.
Akkus G, Evran M, Gungor D, et al. Tinea pedis and onychomycosis frequency in diabetes mellitus patients and diabetic foot ulcers: a cross sectional - observational study. Pakistan J Med Sci 2016;32:891-5. DOI: 10.12669/pjms.324.10027.
Ghannoum M, Isham N. Fungal nail infections (onychomycosis): a never-ending story? PLoS Pathog 2014;10:e1004105. doi: 10.1371/journal.ppat.1004105.
Westerberg DP, Voyack MJ. Onychomycosis: current trends in diagnosis and treatment. Am Fam Physician 2013;88:762–70.
Mayser P, Freund V, Budihardja D. Toenail onychomycosis in diabetic patients: issues and management. Am J Clin Dermatol 2009;10:211-20. doi: 10.2165/00128071-200910040-00001.
Thomas J, Jacobson GA, Narkowicz CK, et al. Toenail onychomycosis: an important global disease burden. J Clin Pharm Ther 2010;35:497-519. doi: 10.1111/j.1365-2710.2009.01107.x.
Moreno G, Arenas R. Other fungi causing onychomycosis. Clin Dermatol 2010;28:160-3. doi: 10.1016/j.clindermatol.2009.12.009.
Baudraz-Rosselet F, Ruffieux C, Lurati M, et al. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents. Dermatology 2010;220:164-8. doi: 10.1159/000277762.
Hashemi SJ, Gerami M, Zibafar E, et al. Onychomycosis in Tehran: mycological study of 504 patients. Mycoses 2010;53:251-5. doi: 10.2165/00128071-200910040-00001.
Farwa U, Abbasi SA, Mirza IA, et al. Non-dermatophyte moulds as pathogens of onychomycosis. J Coll Physicians Surg Pakistan 2011;21:597-600. doi: 10.2011/JCPSP.597600.
Cappuccino JG. Welsh C. Microbiology, a laboratory manual. 11th ed. Harlow: Pearson; 2017.
Klaassen KM, Dulak MG, van de Kerkhof PC, et al. The prevalence of onychomycosis in psoriatic patients: a systematic review. J Eur Acad Dermatol Venereol 2014;28:533-41. doi: 10.1111/jdv.12239.
Archana BR, Beena PM, Kumar S. Study of the distribution of malassezia species in patients with pityriasis versicolor in Kolar Region, Karnataka. Indian J Dermatol 2015; 60:321. doi: 10.4103/0019-5154.156436.
Gupta AK, Drummond-Main C, Cooper EA, et al. Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol 2012;66:494-502. doi: 10.1016/j.jaad.2011.02.038.
Reddy KN, Srikanth BA, Sharan TR, et al. Epidemiological, clinical and cultural study of onychomycosis. Am J Dermatology Venereol 2012;1:35-40. doi: 10.5923/j.ajdv.20120103.01.
Neupane S, Pokhrel DB, Pokhrel BM. Onychomycosis: a clinico-epidemiological study. Nepal Med Coll J 2009;11:92-5.
de Macedo GMC, Nunes S, Barreto T. Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. Diabetol Metab Syndr 2016;8:63. doi: 10.1186/s13098-016-0176-y.
Sugandhi P, Prasanth DA. Prevalence of yeast in diabetic foot infections. Int J Diabetes Dev Ctries 2017;37:50-7. doi: 10.1007/s13410-016-0491-8.
Lima AL, Illing T, Schliemann S, et al. Cutaneous manifestations of diabetes mellitus: a review. Am J Clin Dermatol 2017;18:541-53. doi: 10.1007/s40257-017-0275-z.
Tzar M, Zetti Z, Ramliza R. Dermatomycoses in Kuala Lumpur, Malaysia. Sains Malaysiana 2014;43:1737-42.
Thilak S, Anbumalar M, Sneha PM. Cutaneous fungal infections in subjects with diabetes mellitus. Int J Res Dermatol 2017;3:55-8. DOI: http://dx.doi.org/10.18203/issn.2455-4529. Int J Res Dermatol 2016;44:12.
Santhosh Y, Ramanath K, Naveen M. Fungal infections in diabetes mellitus: an overview. Int J Pharm Sci Rev Res 2011;7:221-5.